As of 2024-12-14, the Fair Value of Egetis Therapeutics AB (publ) (EGTX.ST) is -3.76 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 6.52 SEK, the upside of Egetis Therapeutics AB (publ) is -157.74%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -61.42 | -178.02 | -104.54 | -193.80 | -326.70 | -172.90 |
| YoY growth | 27.74% | -189.84% | 41.28% | -85.38% | -68.58% | -54.96% |
| Market Cap (mil) | 2,342.24 |
| P/E | |
| Forward P/E |
| EPS | -0.75 |
| Avg earnings growth rate | -54.96% |
| TTM earnings | -270.50 |